文献速递淋巴瘤

细胞周期蛋白D1重排的弥漫性大B细胞淋巴瘤——一个演进中的概念

Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.
PubMed 文献 · Leukemia · 2025-11-07

研究通过708例侵袭性B细胞淋巴瘤的FISH筛查未发现CCND1重排,从不同机构收集15例携带CCND1重排的大B细胞肿瘤进行免疫组化和分子特征分析,发现其中3例CD5阳性、所有病例SOX11阴性但细胞周期蛋白D1染色阳性,8例伴有MYC、BCL2或BCL6额外易位,14例可评估病例的WES显示典型DLBCL突变谱,结论认为DLBCL伴CCND1重排确实存在且可不伴额外易位。

要点

  • 708例侵袭性B细胞淋巴瘤FISH筛查未发现CCND1重排,提示此类病例罕见。
  • 15例CCND1重排大B细胞肿瘤均SOX11阴性、细胞周期蛋白D1阳性,3例CD5阳性。
  • 8/15例伴MYC、BCL2或BCL6额外易位,14/14例可评估病例WES显示典型DLBCL突变谱。

核心结论

  • DLBCL伴CCND1重排确实存在,且CCND1重排可不伴额外易位。

研究设计与样本

  • 对708例侵袭性B细胞淋巴瘤进行蛋白表达和FISH筛查,未发现CCND1重排。
  • 从不同机构收集15例携带CCND1重排的大B细胞肿瘤,进行免疫组化和分子特征分析。

主要发现

  • 15例中3例CD5阳性,所有病例SOX11阴性但细胞周期蛋白D1染色阳性且FISH证实CCND1重排。
  • 10/15例通过FISH或WGS确定IG为重排伴侣,同时出现异常VDJ重排和IGH类别转换重组。
  • 8/15例肿瘤伴有涉及MYC、BCL2或BCL6的额外易位。
  • 8/12例可评估病例显示IGHV基因显著突变,重排的IGHV基因存在克隆内变异。
  • 14/14例可评估病例WES显示典型DLBCL的突变谱。

关键数值与推荐

  • 708例侵袭性B细胞淋巴瘤FISH筛查未发现CCND1重排。
  • 15例CCND1重排大B细胞肿瘤中3例CD5阳性、所有病例SOX11阴性。
  • 10/15例确定IG为重排伴侣,8/15例伴MYC、BCL2或BCL6额外易位。
  • 8/12例可评估病例IGHV基因显著突变,14/14例可评估病例WES显示典型DLBCL突变谱。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rearrangement of Cyclin D1 (CCND1-R) is the hallmark genetic lesion of mantle cell lymphoma (MCL). However, recently diffuse large B-cell lymphomas (DLBCL) have been described carrying a CCND1-R, often with additional rearrangements of BCL2, BCL6 and/or MYC raising the question if these are bona fide DLBCL or pleomorphic MCL. Protein expression and fluorescence in situ hybridisation (FISH) screening of 708 aggressive B-cell lymphomas failed to disclose CCND1-R, demonstrating the rarity of such cases. Fifteen large B-cell tumours, with CCND1-R were collected from different institutions and characterized by immunohistochemistry and for their molecular features. Three of 15 cases were CD5 positive, and all cases were negative for SOX11 but exhibited cyclin D1 staining and CCND1-R by FISH. In 10/15 cases IG could be determined as rearrangement partner by FISH or WGS with occurrence of both aberrant VDJ rearrangement and IGH class-switch recombination (CSR). Eight of 15 tumours had additional translocations involving MYC, BCL2, or BCL6. 8/12 evaluable cases showed significantly mutated IGHV genes and evidence of intraclonal variations in their rearranged IGHV genes. WES disclosed a mutational spectrum typical of DLBCL in 14/14 evaluable cases. We conclude that DLBCL CCND1-R do exist and that CCND1-R in DLBCL can occur without additional translocations.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Kurz KS, Zamo A, Drewes C, et al. Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept. Leukemia. 2025. PMID: 41204003. doi:10.1038/s41375-025-02794-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。